SMI
12.530,62
PKT
+48,67
PKT
+0,39
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.02.05 | ABB (Asea Brown Boveri) Neutral | Helvea | |
| 18.02.05 | Zurich Insurance Neutral | JP Morgan | |
| 18.02.05 | ABB (Asea Brown Boveri) In-Line | Goldman Sachs | |
| 21.02.05 | Zurich Insurance Buy | Sarasin Research | |
| 18.02.05 | UBS Overweight | JP Morgan | |
| 18.02.05 | UBS In-Line | Goldman Sachs | |
| 18.02.05 | UBS Overweight | Lehman Brothers | |
| 18.02.05 | Nestlé In-Line | Goldman Sachs | |
| 17.02.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan | |
| 17.02.05 | Zurich Insurance Buy | Merrill Lynch | |
| 17.02.05 | UBS Halten | Helaba Trust | |
| 17.02.05 | ABB (Asea Brown Boveri) Neutral | Sarasin Research | |
| 17.02.05 | Zurich Insurance Buy | Sarasin Research | |
| 17.02.05 | UBS Buy | Sarasin Research | |
| 17.02.05 | ABB (Asea Brown Boveri) Neutral | Helvea | |
| 18.02.05 | Zurich Insurance Neutral | Credit Suisse First Boston | |
| 17.02.05 | UBS Accumulate | Helvea | |
| 02.03.05 | ABB (Asea Brown Boveri) Kaufen | NATIONAL-BANK | |
| 17.02.05 | Zurich Insurance Accumulate | Helvea | |
| 21.02.05 | UBS Übergewichten | Reuschel & Co | |
| 17.02.05 | Roche Hold | Crédit Suisse | |
| 18.02.05 | Holcim Accumulate | Helvea | |
| 17.02.05 | Richemont Verkaufen | Helaba Trust | |
| 17.02.05 | Lonza Reduce | Sarasin Research | |
| 18.02.05 | Lonza Buy | Helvea | |
| 16.02.05 | Holcim Halten | Helaba Trust | |
| 16.02.05 | Lonza Buy | Helvea | |
| 16.02.05 | UBS Kaufen | Hamburger Sparkasse | |
| 14.02.05 | Holcim Verkaufen | Helaba Trust | |
| 15.02.05 | UBS Neutral | Merrill Lynch | |
| 15.02.05 | Swisscom Neutral | Credit Suisse First Boston | |
| 14.02.05 | Nestlé Neutral | Sarasin Research | |
| 11.02.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 14.02.05 | UBS Halten | Helaba Trust | |
| 11.02.05 | Zurich Insurance Neutral | JP Morgan | |
| 14.02.05 | UBS Buy | Sarasin Research | |
| 21.02.05 | Roche Marketperformer | Sparkasse KölnBonn | |
| 11.02.05 | Nestlé Neutral | Sarasin Research | |
| 10.02.05 | Zurich Insurance Buy | Merrill Lynch | |
| 10.02.05 | UBS Buy | Sarasin Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.